Results 111 to 120 of about 27,363 (202)

The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer [PDF]

Context: The significant survival benefit of chemotherapy over best supportive care for locally advanced and metastatic NSCLC has been amply demonstrated in the literature.
Anthony Montella, Bertrand Favier, David Pérol, Frédéric Gomez, Lionel Perrier, Magali Morelle, Marie-Odile Carrère, Nathalie Havet, Paul Rebattu   +8 more
core  

Vinorelbine [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors. [PDF]

BMC Cancer
Eefsen RL, Stenvang J, Bartek J, Pfeiffer P, Tarpgaard L, Theile S, Brünner N, Nielsen DL.   +7 more
europepmc   +1 more source

Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme. [PDF]

Commun Med (Lond)
Angom RS, Rachamala HK, Nakka NMR, Madamsetty VS, Suarez-Meade P, Fernandez-Gil BI, Kulkarni T, Weil RM, Dutta S, Wang E, Bhattacharya S, Pal K, Quinones-Hinojosa A, Mukhopadhyay D.   +13 more
europepmc   +1 more source

Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC Populations. [PDF]

CPT Pharmacometrics Syst Pharmacol
Chen J, Wada R, Zhang N, Graupner V, Morris S, Hu Y, Zhang W, Kassir N, Wu B, Chan P.   +9 more
europepmc   +1 more source

Economic Evaluation of Positron Emission Tomography (PET) in Non Small Cell Lung Cancer (NSCLC), CHERE Working Paper 2007/6 [PDF]

Background: There are several perceived benefits from introducing positron emission tomography (PET) scanning into the staging of non small lung cancer (NSCLC).
Alex Bird, Richard Norman, Stephen Goodall   +2 more
core  

Comparison of the effects of different types of treatment protocols on the median and overall survival rates of non-small cell lung cancer patients: A real-world retrospective study. [PDF]

PLoS One
Siahmansur TJ.
europepmc   +1 more source

Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With <i>EGFR</i> Mutation (West Japan Oncology Group 11719L: ADJUST Study). [PDF]

JTO Clin Res Rep
Shibaki R, Akamatsu H, Okada M, Murotani K, Osuga M, Nishino K, Murakami S, Wakuda K, Mitsudomi T, Tada H, Yoshimura K, Koh Y, Yamamoto N.   +12 more
europepmc   +1 more source

Vinorelbine enhances the efficacy of oncolytic vaccinia virus in a preclinical model of ovarian high-grade serous carcinoma. [PDF]

Mol Ther Oncol
Drymiotou S, Queval CJ, Tyson KE, Sheach LA, Postigo A, Rosa ID, Ennis DP, Howell M, McNeish IA, Way M.   +9 more
europepmc   +1 more source

Survival in Men Treated for Lung Cancer: A Single-Center Retrospective Cohort Study in Poland. [PDF]

Healthcare (Basel)
Królikowska-Jerużalska M, Kurkiewicz M, Moździerz A, Rzepecka-Stojko A, Stojko J.   +4 more
europepmc   +1 more source